Celltrion | 068270 - 债务利息支出

金融业

KRW

KRW 768.81B

现金及等价物

KRW 56.79B

KRW 92.83B

KRW 481.57B

KRW 292.71B

KRW 160.58B

股息收益率

0.38

KRW 13.41B

KRW 19.64B

1.07K

EPS每股收益

KRW 1.35K

股本和储备

KRW 434.82B

KRW 39.29B

债务利息支出

KRW 19B

KRW 779.01M

KRW 411.27B

KRW 37695.95B

KRW 8.82B

KRW 119.22B

KRW 12.9B

普通股股本

KRW 229.65M

58.97

KRW 11.84B

KRW 1240B

销售和管理费用

KRW 9.32B

KRW 126B

贸易债权人

KRW 88.58B

应收帐款人

KRW 2009.82B

	债务利息支出	更改		日
Akebia Therapeutics	362.52M		357.69M	2026-03
Alaunos Therapeutics	USD 1.07M		215K	2023-06
Avita Medical	AUD 1.25M		100K	2025-06
Celltrion	KRW 19B		1.96B	2025-06
Dianthus Therapeutics	USD 4.44M		263K	2024-09
Ionis Pharmaceuticals	USD 17M		1000K	2026-03
IQVIA Holdings	USD 192M		1000K	2026-03
Moderna	USD 11.49B		36B	2026-03
Organon & Co	USD 111M		17M	2026-03
Revvity	USD 24.72M		1.2M	2026-03
Tectonic Therapeutic	USD 246.58M		246.56M	2026-03
Viatris	USD 120.1M		500K	2026-03
Xeris Pharmaceuticals	USD 6.88M		269K	2026-03